Webpackaging logo

    Bona obtains Korean patent for child resistant nasal pumps

    Quick Contact
    Bona obtains Korean patent for child resistant nasal pumps
    Asia, East Asia, China, South Korea, Health, Pharmaceuticals, OTC (Over the Counter) Drugs, Primary Packaging, Caps, Lids, Screw On Closure, CRC Closure, Dispensing Closures, Pumps, Pharmaceutical Components, Nasal Sprays, Active, Smart Packaging, Child-Proofing, CP, Plastic, National Certifications, FDA Approved, < 1 ml, 15 ml, 0.5 oz, 30 ml, 1 oz

    After obtaining the Chinese patent for a new design of child resistant nasal pumps, Bona received the patent certificate from the Korean Intellectual Property office on January 24, 2017.

    Key features of the new child resistant nasal pump:

    • Neck: 18mm Screw on
    • Closure: Locking neck and locking dust cover.
    • Can't be primed by children.
    • Dosage: 50mcl to 220mcl with +/-10% tolerance.
    • Usage: Liquid medicine for nose.
    • Fit for: 15ml and 30ml plastic bottle with screw on neck. Customize bottle welcome.
    • Material: Comply with EUP, EU 10/2011, FDA and USP.
    • Tested by CPSC approved Lab according to Code of Federal Regulations (CFR) Title 16, Part 1700.20.
    • Comply with Quality system ISO15378:2011 which special for primary package manufacturing.

    See also

    BONA Pharma’s disinfection topical spray pump for 100ml PET Bottle

    With the COVID-19 coronavirus epidemic spreading, the World Health Organization is telling people to stay at home, wash hands frequently, and disinfect continuously. In order to help people stay stafe, BONA has launched a multi-volume liquid PET bottle with topical spray pump ideal for disinfection. Although these are difficult times, BONA wants everyone to be strong, stay safe, and act accordingly now in order to reduce the spread of the virus.

    • Company News
    • English
    • Modified 22 Mar 2017
    • Hits 2931

    See us at...